Renee L. Galloway
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Renee L. Galloway has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Benny Borremans
Wildlife Health Ecology Research Organization
2 shared publications - James O. Lloyd-Smith
University of California, Los Angeles
2 shared publications - John A. Crump
Centre for International Health Dunedin Otago University of Otago
2 shared publications - Katherine C. Prager
University of California Los Angeles
2 shared publications - Matthew P. Rubach
Division of Infectious Diseases and International Health, Department of Medicine, Duke University, Durham, North Carolina
2 shared publications - Niel Hens
Vaccin- en Infectieziekten Instituut, Universiteit Antwerpen, Antwerp, Belgium
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 13 February 2024
- Published by Wiley in Tropical Medicine & International Health
- Vol. 29 (3) , 161-172
Global distribution of Leptospira serovar isolations and detections from animal host species: A systematic review and online database
Objectives: Leptospira, the spirochaete causing leptospirosis, can be classified into >250 antigenically distinct serovars. Although knowledge of the animal host species and geographic distribution of Leptospira serovars is critical to understand the human and animal epidemiology of leptospirosis, current data are fragmented. We aimed to systematically review, the literature on animal host species and geographic distribution of Leptospira serovars to examine associations between serovars with animal host species and regions and to identify geographic regions in need of study.Methods: Nine library databases were searched from inception through 9 March 2023 using keywords including Leptospira, animal, and a list of serovars. We sought reports of detection of Leptospira, from any animal, characterised by cross agglutinin absorption test, monoclonal antibody typing, serum factor analysis, or pulsed‐field gel electrophoresis to identify the serovar.Results: We included 409 reports, published from 1927 through 2022, yielding data on 154 Leptospira serovars. The reports included data from 66 (26.5%) of 249 countries. Detections were from 144 animal host species including 135 (93.8%) from the class Mammalia, 5 (3.5%) from Amphibia, 3 (2.1%) from Reptilia, and 1 (0.7%) from Arachnida. Across the animal host species, Leptospira serovars that were detected in the largest number of animal species included Grippotyphosa (n = 39), Icterohaemorrhagiae (n = 29), Pomona (n = 28), Australis (n = 25), and Ballum (n = 25). Of serovars, 76 were detected in a single animal host species. We created an online database to identify animal host species for each serovar by country.Conclusions: We found that many countries have few or no Leptospira serovars detected from animal host species and that many serovars were detected from a single animal species. Our study highlights the importance of efforts to identify animal host species of leptospirosis, especially in places with a high incidence of human leptospirosis. We provide an updated resource for leptospirosis researchers.
- 13 February 2024
- Published by Wiley in Tropical Medicine & International Health
- Vol. 29 (3) , 161-172
Top Cited PapersOpen AccessGlobal distribution of Leptospira serovar isolations and detections from animal host species: A systematic review and online database
Objectives: Leptospira, the spirochaete causing leptospirosis, can be classified into >250 antigenically distinct serovars. Although knowledge of the animal host species and geographic distribution of Leptospira serovars is critical to understand the human and animal epidemiology of leptospirosis, current data are fragmented. We aimed to systematically review, the literature on animal host species and geographic distribution of Leptospira serovars to examine associations between serovars with animal host species and regions and to identify geographic regions in need of study.Methods: Nine library databases were searched from inception through 9 March 2023 using keywords including Leptospira, animal, and a list of serovars. We sought reports of detection of Leptospira, from any animal, characterised by cross agglutinin absorption test, monoclonal antibody typing, serum factor analysis, or pulsed‐field gel electrophoresis to identify the serovar.Results: We included 409 reports, published from 1927 through 2022, yielding data on 154 Leptospira serovars. The reports included data from 66 (26.5%) of 249 countries. Detections were from 144 animal host species including 135 (93.8%) from the class Mammalia, 5 (3.5%) from Amphibia, 3 (2.1%) from Reptilia, and 1 (0.7%) from Arachnida. Across the animal host species, Leptospira serovars that were detected in the largest number of animal species included Grippotyphosa (n = 39), Icterohaemorrhagiae (n = 29), Pomona (n = 28), Australis (n = 25), and Ballum (n = 25). Of serovars, 76 were detected in a single animal host species. We created an online database to identify animal host species for each serovar by country.Conclusions: We found that many countries have few or no Leptospira serovars detected from animal host species and that many serovars were detected from a single animal species. Our study highlights the importance of efforts to identify animal host species of leptospirosis, especially in places with a high incidence of human leptospirosis. We provide an updated resource for leptospirosis researchers.
- Open Access
- 18 December 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-12
Host-response transcriptional biomarkers accurately discriminate bacterial and viral infections of global relevance
Diagnostic limitations challenge management of clinically indistinguishable acute infectious illness globally. Gene expression classification models show great promise distinguishing causes of fever. We generated transcriptional data for a 294-participant (USA, Sri Lanka) discovery cohort with adjudicated viral or bacterial infections of diverse etiology or non-infectious disease mimics. We then derived and cross-validated gene expression classifiers including: 1) a single model to distinguish bacterial vs. viral (Global Fever-Bacterial/Viral [GF-B/V]) and 2) a two-model system to discriminate bacterial and viral in the context of noninfection (Global Fever-Bacterial/Viral/Non-infectious [GF-B/V/N]). We then translated to a multiplex RT-PCR assay and independent validation involved 101 participants (USA, Sri Lanka, Australia, Cambodia, Tanzania). The GF-B/V model discriminated bacterial from viral infection in the discovery cohort an area under the receiver operator curve (AUROC) of 0.93. Validation in an independent cohort demonstrated the GF-B/V model had an AUROC of 0.84 (95% CI 0.76–0.90) with overall accuracy of 81.6% (95% CI 72.7–88.5). Performance did not vary with age, demographics, or site. Host transcriptional response diagnostics distinguish bacterial and viral illness across global sites with diverse endemic pathogens.
- 18 December 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-12
Open AccessHost-response transcriptional biomarkers accurately discriminate bacterial and viral infections of global relevance
Diagnostic limitations challenge management of clinically indistinguishable acute infectious illness globally. Gene expression classification models show great promise distinguishing causes of fever. We generated transcriptional data for a 294-participant (USA, Sri Lanka) discovery cohort with adjudicated viral or bacterial infections of diverse etiology or non-infectious disease mimics. We then derived and cross-validated gene expression classifiers including: 1) a single model to distinguish bacterial vs. viral (Global Fever-Bacterial/Viral [GF-B/V]) and 2) a two-model system to discriminate bacterial and viral in the context of noninfection (Global Fever-Bacterial/Viral/Non-infectious [GF-B/V/N]). We then translated to a multiplex RT-PCR assay and independent validation involved 101 participants (USA, Sri Lanka, Australia, Cambodia, Tanzania). The GF-B/V model discriminated bacterial from viral infection in the discovery cohort an area under the receiver operator curve (AUROC) of 0.93. Validation in an independent cohort demonstrated the GF-B/V model had an AUROC of 0.84 (95% CI 0.76–0.90) with overall accuracy of 81.6% (95% CI 72.7–88.5). Performance did not vary with age, demographics, or site. Host transcriptional response diagnostics distinguish bacterial and viral illness across global sites with diverse endemic pathogens.
- Open Access
- 21 August 2023
- Published by Wiley in Methods in Ecology and Evolution
- Vol. 14 (10) , 2654-2667
Inferring time of infection from field data using dynamic models of antibody decay
Studies of infectious disease ecology would benefit greatly from knowing when individuals were infected, but estimating this time of infection can be challenging, especially in wildlife. Time of infection can be estimated from various types of data, with antibody‐level data being one of the most promising sources of information. The use of antibody levels to back‐calculate infection time requires the development of a host‐pathogen system‐specific model of antibody dynamics, and a leading challenge in such quantitative serology approaches is how to model antibody dynamics in the absence of experimental infection data. We present a way to model antibody dynamics in a Bayesian framework that facilitates the incorporation of all available information about potential infection times and apply the model to estimate infection times of Channel Island foxes infected withLeptospira interrogans. Using simulated data, we show that the approach works well across a broad range of parameter settings and can lead to major improvements in infection time estimates that depend on system characteristics such as antibody decay rate and variation in peak antibody levels after exposure. When applied to field data we saw reductions up to 83% in the window of possible infection times. The method substantially simplifies the challenge of modelling antibody dynamics in the absence of individuals with known infection times, opens up new opportunities in wildlife disease ecology and can even be applied to cross‐sectional data once the model is trained.
- 21 August 2023
- Published by Wiley in Methods in Ecology and Evolution
- Vol. 14 (10) , 2654-2667
Open AccessInferring time of infection from field data using dynamic models of antibody decay
Studies of infectious disease ecology would benefit greatly from knowing when individuals were infected, but estimating this time of infection can be challenging, especially in wildlife. Time of infection can be estimated from various types of data, with antibody‐level data being one of the most promising sources of information. The use of antibody levels to back‐calculate infection time requires the development of a host‐pathogen system‐specific model of antibody dynamics, and a leading challenge in such quantitative serology approaches is how to model antibody dynamics in the absence of experimental infection data. We present a way to model antibody dynamics in a Bayesian framework that facilitates the incorporation of all available information about potential infection times and apply the model to estimate infection times of Channel Island foxes infected withLeptospira interrogans. Using simulated data, we show that the approach works well across a broad range of parameter settings and can lead to major improvements in infection time estimates that depend on system characteristics such as antibody decay rate and variation in peak antibody levels after exposure. When applied to field data we saw reductions up to 83% in the window of possible infection times. The method substantially simplifies the challenge of modelling antibody dynamics in the absence of individuals with known infection times, opens up new opportunities in wildlife disease ecology and can even be applied to cross‐sectional data once the model is trained.
- Open Access
Inferring time of infection from field data using dynamic models of antibody decay
Studies of infectious disease ecology often rely heavily on knowing when individuals were infected, but estimating this time of infection can be challenging, especially in wildlife. Time of infection can be estimated from various types of data, with antibody level data being one of the most promising sources of information. The use of antibody levels to back-calculate infection time requires the development of a host-pathogen system-specific model of antibody dynamics, and a leading challenge in such quantitative serology approaches is how to model antibody dynamics in the absence of experimental infection data. Here, we present a way to do this in a Bayesian framework that facilitates the incorporation of all available information about potential infection times. We apply the model to estimate infection times of Channel Island foxes infected with Leptospira interrogans , leading to reductions of 51-92% in the window of possible infection times. Using simulated data, we show that the approach works well across a broad range of parameter settings and can lead to major improvements of infection time estimates that depend on system characteristics such as antibody decay rate and variation in peak antibody levels after exposure. The method substantially simplifies the challenge of modeling antibody dynamics in the absence of individuals with known infection times, opens up new opportunities in wildlife disease ecology, and can even be applied to cross-sectional data once the model is trained.
Open AccessInferring time of infection from field data using dynamic models of antibody decay
Studies of infectious disease ecology often rely heavily on knowing when individuals were infected, but estimating this time of infection can be challenging, especially in wildlife. Time of infection can be estimated from various types of data, with antibody level data being one of the most promising sources of information. The use of antibody levels to back-calculate infection time requires the development of a host-pathogen system-specific model of antibody dynamics, and a leading challenge in such quantitative serology approaches is how to model antibody dynamics in the absence of experimental infection data. Here, we present a way to do this in a Bayesian framework that facilitates the incorporation of all available information about potential infection times. We apply the model to estimate infection times of Channel Island foxes infected with Leptospira interrogans , leading to reductions of 51-92% in the window of possible infection times. Using simulated data, we show that the approach works well across a broad range of parameter settings and can lead to major improvements of infection time estimates that depend on system characteristics such as antibody decay rate and variation in peak antibody levels after exposure. The method substantially simplifies the challenge of modeling antibody dynamics in the absence of individuals with known infection times, opens up new opportunities in wildlife disease ecology, and can even be applied to cross-sectional data once the model is trained.
- 20 October 2014
- Published by Environmental Health Perspectives in ISEE Conference Abstracts
- Vol. 2014 (1)
Leptospira Infection and Biomarkers of Kidney Injury among Nicaraguan Workers
Environmental Health Perspectives is an Open Access journal published by the National Institute of Environmental Health Sciences. Environmental Health Perspectives is an Open Access journal published by the National Institute of Environmental Health Sciences.
- 20 October 2014
- Published by Environmental Health Perspectives in ISEE Conference Abstracts
- Vol. 2014 (1)
Leptospira Infection and Biomarkers of Kidney Injury among Nicaraguan Workers
Environmental Health Perspectives is an Open Access journal published by the National Institute of Environmental Health Sciences. Environmental Health Perspectives is an Open Access journal published by the National Institute of Environmental Health Sciences.